These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 187020)

  • 21. Improving the cellular pertussis vaccine: increased potency and consistency.
    Thalen M; van der Ark A; van den Ijssel J; van Straaten I; Jansen D; Beuvery C; Martens D; Tramper J
    Vaccine; 2008 Jan; 26(5):653-63. PubMed ID: 18155325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial effect of human milk on Bordetella pertussis.
    Redhead K; Hill T; Mulloy B
    FEMS Microbiol Lett; 1990 Aug; 58(3):269-73. PubMed ID: 2227362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines.
    Kamachi K; Fukuda T; Han HJ; Toyoizumi-Ajisaka H; Mochida K; Konda T; Horiuchi Y; Arakawa Y;
    Biologicals; 2010 Mar; 38(2):290-3. PubMed ID: 20064727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of culture methods on the biological activities of Bordetella pertussis].
    Hirayanagi F
    Nihon Saikingaku Zasshi; 1969 Jan; 24(1):8-14. PubMed ID: 4306072
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of a fermentation process in the production of pertussis vaccine].
    Recamier L; Medina A; Rodríguez H
    Salud Publica Mex; 1981; 23(6):563-73. PubMed ID: 6278655
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cultivation of Bordetella pertussis in liquid semisynthetic nutrient media with ion-exchange resins].
    Sukhinova EE; Shmeleva EI; Mertsalova NU; Iulin II; Golshmid VK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):64-7. PubMed ID: 6277111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis.
    Thalen M; Venema M; van den IJssel J; Berwald L; Beuvery C; Martens D; Tramper J
    Biologicals; 2006 Sep; 34(3):213-20. PubMed ID: 16497513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and analysis of the antigenicity of a 69,000 Da protein from Bordetella pertussis.
    Gould-Kostka JL; Burns DL; Brennan MJ; Manclark CR
    FEMS Microbiol Lett; 1990 Feb; 55(3):285-9. PubMed ID: 2323550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stainer and Scholte's pertussis medium with an alternative buffer.
    Lothe RA; Frøholm LO; Westre G; Kjennerud U
    J Biol Stand; 1985 Apr; 13(2):129-34. PubMed ID: 2860114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
    Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis.
    Dolby JM; Ackers JP
    J Gen Microbiol; 1975 Apr; 87(2):239-44. PubMed ID: 49392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine.
    Bogdan JA; Nazario-Larrieu J; Sarwar J; Alexander P; Blake MS
    Infect Immun; 2001 Nov; 69(11):6823-30. PubMed ID: 11598055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines.
    Blaskett AC; Cox JC
    Epidemiol Infect; 1988 Jun; 100(3):335-44. PubMed ID: 2897927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
    Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine production as a unit process.
    van Hemert P
    Prog Ind Microbiol; 1974; 13():151-271. PubMed ID: 4373785
    [No Abstract]   [Full Text] [Related]  

  • 40. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
    van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
    Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.